SCMOM 2012_MaxCyte – Video

Posted: November 30, 2012 at 12:42 pm




SCMOM 2012_MaxCyte
MaxCyte is the leader in scalable and clinical cell transfection, bringing to market its patented flow electroporation technology. MaxCyte is applying its significant capabilities in the discovery, development, and manufacturing of virtually all classes of innovative therapeutics targeting a broad range of diseases. MaxCyte #39;s customers and partners utilize its technologies in the development and commercialization of cell-based therapies in regenerative medicine and active cell immunotherapies and in the discovery and development of protein drugs, monoclonal antibodies, vaccines, and small molecule drugs. This clinical-grade cell loading technology is fully developed, well validated and has received MF designation with CBER at US FDA. http://www.maxcyte.com Presenter: Douglas Doerfler, President and CEO, MaxCyteFrom:AllianceRegenMedViews:2 1ratingsTime:13:14More inScience Technology

Read more:
SCMOM 2012_MaxCyte - Video

Related Posts

Comments are closed.

Archives